Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2026-03-04 @ 1:04 AM
Study NCT ID:
NCT04071405
Status:
COMPLETED
Last Update Posted:
2024-09-03
First Post:
2019-08-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-26
First Submit QC Date:
None
Study First Post Date:
2019-08-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-06
Results First Submit QC Date:
None
Results First Post Date:
2024-09-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-08
Last Update Post Date:
2024-09-03
Last Update Post Date Type:
ACTUAL